AST5902 (trimesylate) - CAS 2929417-90-1

AST5902 trimesylate is the primary metabolite of Alflutinib (AST2818) both in vivo and in vitro. It exhibits antitumor activity. Alflutinib functions as an EGFR inhibitor.

Drug Metabolite, EGFR

Angiogenesis, Metabolism, JAK/STAT signaling, Tyrosine Kinase/Adaptors

2929326

C30H41F3N8O11S3

842.884

O=C(NC1=CC(NC2=NC(C3=CN(C)C4=C3C=CC=C4)=CC=N2)=C(OCC(F)(F)F)N=C1N(CCNC)C)C=C.O=S(O)(C)=O.O=S(O)(C)=O.O=S(O)(C)=O

-20°C

Ice Packs

Small Compound